Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kiara Health is a private South African pharmaceutical manufacturing and healthcare solutions company focused on local production, commercialization, and distribution of medicines, diagnostics, and selected medical technologies across Africa. The company operates a 52,000 m2 pharmaceutical production site near Johannesburg and holds SAHPRA GMP manufacturing licensure, enabling both production of its own marketed products and contract manufacturing for multinational pharmaceutical partners. Its commercial portfolio spans innovator and generic medicines, OTC products, women’s health offerings, diagnostics, and infection-prevention technologies. Kiara has highlighted strategic interests in women’s health, HIV prevention, cervical cancer screening, and infectious diseases such as TB, malaria, and STIs. The company also works as a market-access and commercialization partner for external product owners in South Africa and other African markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kiara Healthcare.